Anonymous ID: 448618 Feb. 3, 2019, 7:21 p.m. No.5021234   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun

Sells this amount 6 days before announcing earnings. Nothing to see here.

Way over the 1% threshold the SEC shill with the "muh rules and regulations" bullshit.

 

Top portion of the sauce show the total sales vs buys. $50,595 in buys vs $34,921,647 in sales since Feb '17

 

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. The Company's programs include approximately three cancer drugs, binimetinib, encorafenib and selumetinib (partnered with AstraZeneca, PLC).

 

With that news last week of the israeli company potentially having a cure for cancer it makes you wonder if he knew this.

 

https://www.secform4.com/insider-trading/1100412.htm

 

https://www.marketscreener.com/ARRAY-BIOPHARMA-INC-8433/company/